tiprankstipranks
Advertisement
Advertisement
CytoDyn releases 2025 December letter to shareholders
PremiumThe FlyCytoDyn releases 2025 December letter to shareholders
4M ago
CytoDyn announces findings on PD-L1 survival in triple-negative breast cancer
Premium
The Fly
CytoDyn announces findings on PD-L1 survival in triple-negative breast cancer
4M ago
CytoDyn Reaches Settlement in Securities Lawsuit
Premium
Company Announcements
CytoDyn Reaches Settlement in Securities Lawsuit
4M ago
CytoDyn’s Phase 2 Study: A Potential Breakthrough in mCRC Treatment
PremiumCompany AnnouncementsCytoDyn’s Phase 2 Study: A Potential Breakthrough in mCRC Treatment
5M ago
CytoDyn CEO says moving with ‘discipline and urgency’ along ‘well-defined’ path
Premium
The Fly
CytoDyn CEO says moving with ‘discipline and urgency’ along ‘well-defined’ path
6M ago
CytoDyn to present poster at AACR conference on mTNBC
Premium
The Fly
CytoDyn to present poster at AACR conference on mTNBC
7M ago
CytoDyn Appoints Robert Hoffman as New CFO
PremiumCompany AnnouncementsCytoDyn Appoints Robert Hoffman as New CFO
11M ago
CytoDyn appoints Robert Hoffman as CFO
Premium
The Fly
CytoDyn appoints Robert Hoffman as CFO
11M ago
CytoDyn leadership team to attend ESMO Breast Cancer meeting
Premium
The Fly
CytoDyn leadership team to attend ESMO Breast Cancer meeting
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100